Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 14

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 14
---
 terrorism or military actions,
(D) any action taken, or omitted to be taken, by the Investor, its affiliates or its or their respective successors and assigns with respect
to the transactions contemplated by this Agreement or the Registration Rights Agreement, (E) the effect of any change in applicable laws
or accounting rules that does not have a disproportionate effect on the Company and its Subsidiaries, taken as a whole, or (F) any change
resulting from compliance with terms of this Agreement or the Registration Rights Agreement or the consummation of the transactions contemplated
by this Agreement and the Registration Rights Agreement, or (iii) the Company’s ability to perform in any material respect on a
timely basis its obligations under any Transaction Document to be performed as of the date of determination.

(z) “” means the first day of the month immediately following the thirty-six (36) month anniversary of the Commencement Date.

(aa) “”
means the period commencing at 9:30 a.m., Eastern time, on the fifth (5th) Business Day immediately prior to the filing of any post-effective
amendment to the Registration Statement (as defined herein) or New Registration Statement (as such term is defined in the Registration
Rights Agreement), and ending at 9:30 a.m., Eastern time, on the Business Day immediately following, the effective date of any post-effective
amendment to the Registration Statement (as defined herein) or New Registration Statement (as such term is defined in the Registration
Rights Agreement).

(bb) “” means any securities of the Company entitling the holder thereof to acquire at any time Ordinary Shares or
Depositary Shares, including, without limitation, any debt, preferred share, right, option, warrant or other instrument that is at any
time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Ordinary Shares or Depositary
Shares.

(cc) “”
means an individual or entity including but not limited to any limited liability company, a partnership, a joint venture, a corporation,
a trust, an unincorporated organization and a government or any department or agency thereof.

(dd) “” means The Nasdaq Capital Market (or any nationally recognized successor thereto); provided, however, that in the event
the Company’s Depositary Shares are not listed on The Nasdaq Capital Market (or any nationally recognized successor thereto) but
is then listed or traded on The Nasdaq Global Market, The Nasdaq Global Select